In vivo characterisation of the chemokine recep-tor CXCR4 to detect an inflammation in athero-sclerotic plaques by means of PET/MR

This project shall carry out the necessary toxicity and dose tests for an initial application in humans. If these tests are successfully completed, the proof of concept shall be demonstrated in patients, whereby it shall be determined whether the incorporated amount of 68Ga-Pentixafor correlates with the expression of CXCR4
- Project Term
- 2017 - 2017
- Granted Budget
- € 28.140
- Indication
- atherosclerosis
- Therapeutic Principle
- Imaging
- Principal Investigator
- Markus Schwaiger (Klinikum rechts der Isar der Technischen Universität München)